---
document_datetime: 2025-12-02 06:12:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/eurartesim.html
document_name: eurartesim.html
version: success
processing_time: 0.1317059
conversion_datetime: 2025-12-24 19:22:52.71579
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Eurartesim

[RSS](/en/individual-human-medicine.xml/65487)

##### Authorised

This medicine is authorised for use in the European Union

piperaquine tetraphosphate / artenimol Medicine Human Authorised

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Eurartesim](#more-information-on-eurartesim-448)
- [More information on Eurartesim](#related-medicines)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR) for Eurartesim. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Eurartesim.

Expand section

Collapse section

## What is Eurartesim?

Eurartesim is a malaria medicine that contains the active substances piperaquine tetraphosphate and artenimol. It is available as tablets (160 mg/20 mg; 320 mg/40 mg).

## What is Eurartesim used for?

Eurartesim is used to treat uncomplicated malaria caused by the *Plasmodium falciparum* parasite. 'Uncomplicated' means the disease does not involve severe, life-threatening symptoms. It can be used in adults and children aged 6 months and over and weighing 5 kg or more.

The medicine can only be obtained with a prescription.

## How is Eurartesim used?

Eurartesim is taken once a day for three consecutive days, at the same time each day. The dose is determined by the patient's body weight. The tablets are swallowed with water when the stomach is empty, at least three hours before or after a meal. The tablets may be crushed and mixed with water if needed. For more information, see the package leaflet.

## How does Eurartesim work?

Malaria is an infection caused by a parasite known as Plasmodium and spread through the bite of an infected mosquito. The active substances in Eurartesim, piperaquine tetraphosphate and artenimol, are antimalarial substances which kill the *P. falciparum* parasite. Piperaquine tetraphosphate is a so-called bisquinolone. It is chemically related to other widely available medicines used to treat malaria. It is thought to work by blocking a step in the parasite's metabolism needed for its survival. Artenimol is a derivative of the naturally occurring substance artemisinin. Although the exact way in which it kills the parasite is not fully understood, it is believed to damage the parasite membrane.

## How has Eurartesim been studied?

Eurartesim was investigated in two main studies in patients with uncomplicated *P. falciparum* malaria. In the first study, Eurartesim was compared with another malaria medicine containing artesunate and mefloquine in 1,150 patients. The main measure of effectiveness was the proportion of patients who were cured 63 days after treatment. In the second study, Eurartesim was compared with another medicine containing artemether and lumefantrine in 1,553 children. The main measure of effectiveness was the proportion of patients who were cured 28 days after treatment.

## What benefit has Eurartesim shown during the studies?

Eurartesim was shown to be effective in treating uncomplicated *P. falciparum* malaria. In the first study, 63 days after treatment 97% of patients who received Eurartesim had been cured, compared with 95% of patients treated with the comparator medicine. In the second study, 28 days after treatment 93% of patients who received Eurartesim had been cured, compared with 95% of patients treated with the comparator medicine.

## What is the risk associated with Eurartesim?

In adults, the most common side effects with Eurartesim (seen in between 1 and 10 patients in 100) are anaemia (low red blood cell counts), headache, QTc interval prolongation (an alteration of the electrical activity of the heart, which can cause a life-threatening abnormality of heart rhythm), tachycardia (rapid heartbeat), weakness, and fever. In children, the most common side effects with Eurartesim (seen in more than 1 patient in 10) were influenza (flu), cough and fever. For the full list of all side effects with Eurartesim, see the package leaflet.

Eurartesim must not be used in patients with severe malaria. It must not be used in patients who have or are at risk of QTc interval prolongation or cardiac arrhythmias (unstable heart rhythm) or who are taking medicines that can affect heart rhythm. For the full list of restrictions, see the package leaflet.

## Why has Eurartesim been approved?

The CHMP considered that Eurartesim had been shown to be effective in treating uncomplicated *P. falciparum* malaria while the side effects were similar to those seen with comparable treatments. The CHMP noted the potential risk for QTc interval prolongation, and included restrictions in the product information to minimise the risk to patients. The Committee noted that Eurartesim meets World Health Organization recommendations for *P. falciparum* malaria treatment by offering a new alternative artemisinin combination therapy containing two active substances which work in different ways. Therefore, the Committee concluded that the benefits of Eurartesim outweigh its risks and recommended that it be granted marketing authorisation.

## What measures are being taken to ensure the safe use of Eurartesim?

The company that markets Eurartesim will provide all doctors expected to prescribe or use Eurartesim with an educational pack containing important information on the correct use of the medicine, including a checklist of the medicines that Eurartesim must not be given with, to reduce the risk of QTc interval prolongation. The Eurartesim carton is to include instructions to take the medicine at least 3 hours before or after food. The company will also complete a study on Eurartesim's effects on the heart.

Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Eurartesim have also been included in the summary of product characteristics and the package leaflet.

## Other information about Eurartesim

The European Commission granted a marketing authorisation valid throughout the European Union for Eurartesim on 27 October 2011.

For more information about treatment with Eurartesim, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Eurartesim : EPAR - Summary for the public

Reference Number: EMA/531720/2011

English (EN) (80.9 KB - PDF)

**First published:** 28/11/2011

**Last updated:** 26/09/2016

[View](/en/documents/overview/eurartesim-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-379)

български (BG) (108.57 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/bg/documents/overview/eurartesim-epar-summary-public_bg.pdf)

español (ES) (78.97 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/es/documents/overview/eurartesim-epar-summary-public_es.pdf)

čeština (CS) (105.59 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/cs/documents/overview/eurartesim-epar-summary-public_cs.pdf)

dansk (DA) (78.6 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/da/documents/overview/eurartesim-epar-summary-public_da.pdf)

Deutsch (DE) (80.53 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/de/documents/overview/eurartesim-epar-summary-public_de.pdf)

eesti keel (ET) (77.75 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/et/documents/overview/eurartesim-epar-summary-public_et.pdf)

ελληνικά (EL) (110.58 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/el/documents/overview/eurartesim-epar-summary-public_el.pdf)

français (FR) (79.88 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/fr/documents/overview/eurartesim-epar-summary-public_fr.pdf)

hrvatski (HR) (98.53 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/hr/documents/overview/eurartesim-epar-summary-public_hr.pdf)

italiano (IT) (78.78 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/it/documents/overview/eurartesim-epar-summary-public_it.pdf)

latviešu valoda (LV) (103.87 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/lv/documents/overview/eurartesim-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (103.6 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/lt/documents/overview/eurartesim-epar-summary-public_lt.pdf)

magyar (HU) (100.63 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/hu/documents/overview/eurartesim-epar-summary-public_hu.pdf)

Malti (MT) (106.47 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/mt/documents/overview/eurartesim-epar-summary-public_mt.pdf)

Nederlands (NL) (79.27 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/nl/documents/overview/eurartesim-epar-summary-public_nl.pdf)

polski (PL) (105.86 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/pl/documents/overview/eurartesim-epar-summary-public_pl.pdf)

português (PT) (79.38 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/pt/documents/overview/eurartesim-epar-summary-public_pt.pdf)

română (RO) (102.34 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/ro/documents/overview/eurartesim-epar-summary-public_ro.pdf)

slovenčina (SK) (105.48 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/sk/documents/overview/eurartesim-epar-summary-public_sk.pdf)

slovenščina (SL) (95.22 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/sl/documents/overview/eurartesim-epar-summary-public_sl.pdf)

Suomi (FI) (78.17 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/fi/documents/overview/eurartesim-epar-summary-public_fi.pdf)

svenska (SV) (78.75 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

26/09/2016

[View](/sv/documents/overview/eurartesim-epar-summary-public_sv.pdf)

## Product information

Eurartesim : EPAR - Product Information

English (EN) (1.04 MB - PDF)

**First published:** 28/11/2011

**Last updated:** 04/09/2025

[View](/en/documents/product-information/eurartesim-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-736)

български (BG) (736.43 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/bg/documents/product-information/eurartesim-epar-product-information_bg.pdf)

español (ES) (591.33 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/es/documents/product-information/eurartesim-epar-product-information_es.pdf)

čeština (CS) (666.26 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/cs/documents/product-information/eurartesim-epar-product-information_cs.pdf)

dansk (DA) (614.95 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/da/documents/product-information/eurartesim-epar-product-information_da.pdf)

Deutsch (DE) (628.8 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/de/documents/product-information/eurartesim-epar-product-information_de.pdf)

eesti keel (ET) (575.28 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/et/documents/product-information/eurartesim-epar-product-information_et.pdf)

ελληνικά (EL) (829.46 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/el/documents/product-information/eurartesim-epar-product-information_el.pdf)

français (FR) (635.62 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/fr/documents/product-information/eurartesim-epar-product-information_fr.pdf)

hrvatski (HR) (683.24 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/hr/documents/product-information/eurartesim-epar-product-information_hr.pdf)

íslenska (IS) (577.12 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/is/documents/product-information/eurartesim-epar-product-information_is.pdf)

italiano (IT) (624.01 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/it/documents/product-information/eurartesim-epar-product-information_it.pdf)

latviešu valoda (LV) (660.07 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/lv/documents/product-information/eurartesim-epar-product-information_lv.pdf)

lietuvių kalba (LT) (643.14 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/lt/documents/product-information/eurartesim-epar-product-information_lt.pdf)

magyar (HU) (780.97 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/hu/documents/product-information/eurartesim-epar-product-information_hu.pdf)

Malti (MT) (764.01 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/mt/documents/product-information/eurartesim-epar-product-information_mt.pdf)

Nederlands (NL) (589.8 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/nl/documents/product-information/eurartesim-epar-product-information_nl.pdf)

norsk (NO) (591.41 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/no/documents/product-information/eurartesim-epar-product-information_no.pdf)

polski (PL) (672.39 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/pl/documents/product-information/eurartesim-epar-product-information_pl.pdf)

português (PT) (620.6 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/pt/documents/product-information/eurartesim-epar-product-information_pt.pdf)

română (RO) (707.69 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/ro/documents/product-information/eurartesim-epar-product-information_ro.pdf)

slovenčina (SK) (699.38 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/sk/documents/product-information/eurartesim-epar-product-information_sk.pdf)

slovenščina (SL) (628.42 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/sl/documents/product-information/eurartesim-epar-product-information_sl.pdf)

Suomi (FI) (609.9 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/fi/documents/product-information/eurartesim-epar-product-information_fi.pdf)

svenska (SV) (610.03 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

04/09/2025

[View](/sv/documents/product-information/eurartesim-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000295016 03/09/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Eurartesim : EPAR - All Authorised presentations

English (EN) (58.2 KB - PDF)

**First published:** 28/11/2011

**Last updated:** 01/09/2021

[View](/en/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-423)

български (BG) (98.96 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/bg/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_bg.pdf)

español (ES) (80.25 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/es/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_es.pdf)

čeština (CS) (141.3 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/cs/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (59.12 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/da/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (79.6 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/de/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (144.11 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/et/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (140.35 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/el/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_el.pdf)

français (FR) (63.26 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/fr/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (115.79 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/hr/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (79.63 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/is/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_is.pdf)

italiano (IT) (57.92 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/it/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (127.1 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/lv/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (95.33 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/lt/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (98.5 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/hu/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (77.06 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/mt/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (98.45 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/nl/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (103.65 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/no/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_no.pdf)

polski (PL) (67.81 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/pl/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_pl.pdf)

português (PT) (58.3 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/pt/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_pt.pdf)

română (RO) (113.57 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/ro/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (100.97 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/sk/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (88.47 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/sl/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (62.24 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/fi/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (80.11 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

01/09/2021

[View](/sv/documents/all-authorised-presentations/eurartesim-epar-all-authorised-presentations_sv.pdf)

Eurartesim : EPAR - Conditions imposed on member states for safe and effective use

English (EN) (28.15 KB - PDF)

**First published:** 28/11/2011

**Last updated:** 28/11/2011

[View](/en/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_en.pdf)

[Other languages (21)](#file-language-dropdown-139)

български (BG) (170.93 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/bg/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_bg.pdf)

español (ES) (30.23 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/es/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_es.pdf)

čeština (CS) (151.4 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/cs/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_cs.pdf)

dansk (DA) (29.33 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/da/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_da.pdf)

Deutsch (DE) (30.42 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/de/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_de.pdf)

eesti keel (ET) (28.19 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/et/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_et.pdf)

ελληνικά (EL) (164.42 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/el/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_el.pdf)

français (FR) (29.85 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/fr/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_fr.pdf)

italiano (IT) (29.41 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/it/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_it.pdf)

latviešu valoda (LV) (149.11 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/lv/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_lv.pdf)

lietuvių kalba (LT) (148.79 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/lt/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_lt.pdf)

magyar (HU) (144.91 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/hu/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_hu.pdf)

Malti (MT) (177.13 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/mt/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_mt.pdf)

Nederlands (NL) (29.33 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/nl/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_nl.pdf)

polski (PL) (155.19 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/pl/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_pl.pdf)

português (PT) (30.34 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/pt/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_pt.pdf)

română (RO) (147.29 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/ro/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_ro.pdf)

slovenčina (SK) (151.03 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/sk/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_sk.pdf)

slovenščina (SL) (112.6 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/sl/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_sl.pdf)

Suomi (FI) (29.59 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/fi/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_fi.pdf)

svenska (SV) (29.61 KB - PDF)

**First published:**

28/11/2011

**Last updated:**

28/11/2011

[View](/sv/documents/conditions-member-states/eurartesim-epar-conditions-imposed-member-states-safe-and-effective-use_sv.pdf)

## Product details

Name of medicine Eurartesim Active substance

- piperaquine tetraphosphate
- artenimol

International non-proprietary name (INN) or common name

- piperaquine tetraphosphate
- artenimol

Therapeutic area (MeSH) Malaria Anatomical therapeutic chemical (ATC) code P01BF05

### Pharmacotherapeutic group

Antiprotozoals

### Therapeutic indication

Eurartesim is indicated for the treatment of uncomplicated *Plasmodium falciparum* malaria in adults, children and infants 6 months and over and weighing 5 kg or more.

Consideration should be given to official guidance on the appropriate use of antimalarial agents.

## Authorisation details

EMA product number EMEA/H/C/001199 Marketing authorisation holder

Alfasigma S.p.A.

Via Ragazzi del '99, n.5

Marketing authorisation issued 27/10/2011 Revision 15

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Eurartesim : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (173.69 KB - PDF)

**First published:** 04/09/2025

[View](/en/documents/procedural-steps-after/eurartesim-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Eurartesim : EPAR - Procedural steps taken and scientific information after authorisation (archive)

English (EN) (149.72 KB - PDF)

**First published:** 29/05/2012

**Last updated:** 04/09/2025

[View](/en/documents/procedural-steps-after/eurartesim-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf)

Eurartesim-H-C-PSUSA-00001069-202210 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/392409/2023

English (EN) (92.86 KB - PDF)

**First published:** 30/08/2023

[View](/en/documents/scientific-conclusion/eurartesim-h-c-psusa-00001069-202210-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

Eurartesim-H-C-PSUSA-00001069-201910 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/473772/2021

English (EN) (138.24 KB - PDF)

**First published:** 01/09/2021

[View](/en/documents/scientific-conclusion/eurartesim-h-c-psusa-00001069-201910-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

Eurartesim-H-C-1199-P46-0016 : EPAR - Assessment Report

Adopted

Reference Number: EMA/103576/2018

English (EN) (1.17 MB - PDF)

**First published:** 21/02/2018

**Last updated:** 21/02/2018

[View](/en/documents/variation-report/eurartesim-h-c-1199-p46-0016-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Eurartesim : EPAR - Public assessment report

Adopted

Reference Number: EMA/739355/2011

English (EN) (2.81 MB - PDF)

**First published:** 28/11/2011

**Last updated:** 28/11/2011

[View](/en/documents/assessment-report/eurartesim-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Eurartesim

Adopted

Reference Number: EMA/CHMP/207988/2011

English (EN) (45.43 KB - PDF)

**First published:** 24/06/2011

**Last updated:** 24/06/2011

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-eurartesim_en.pdf)

#### More information on Eurartesim

This product is no longer an orphan medicine. It was originally [designated an orphan medicine](/en/medicines/human/orphan-designations/eu307468) on 3 August 2007. Eurartesim was withdrawn from the Community register of orphan medicinal products in July 2011 upon request of the marketing authorisation holder at the time of the granting of a marketing authorisation.

#### More information on Eurartesim

- [EMEA-000153-PIP01-07-M05 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000153-pip01-07-m05)
- [Pregnancy Registry for Eurartesim - post-authorisation study](https://catalogues.ema.europa.eu/study/30212)
- [Safety registry for Eurartesim - post-authorisation study](https://catalogues.ema.europa.eu/study/28484)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 04/09/2025

## Share this page

[Back to top](#main-content)